Intrahepatic cholestasis of pregnancy (ICP) is characterized by unexplained distressing
pruritus in the mother and poses significant risk to the fetus of perinatal mortality. Occurring …

Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver
disorder. Maternal effects of ICP are mild; however, there is a clear association between ICP …

Intrahepatic cholestasis of pregnancy (ICP) is associated with poor perinatal outcomes in
some women such as preterm delivery and fetal demise. Ursodeoxycholic acid (UDCA) is …

Intrahepatic cholestasis of pregnancy is the most common liver disease occurring in the
second half of pregnancy, characterized by pruritus and elevated serum bile acids often …

Intrahepatic cholestasis of pregnancy (ICP) is a reversible pregnancy-specific cholestatic
condition characterized by pruritus, elevated liver enzymes, and increased serum bile acids …

Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from
ursodeoxycholic acid (UDCA) treatment. Since there is still certain reluctance to use UDCA …

Background Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder
specific to pregnancy and presents with maternal pruritus, raised concentrations of serum …

Intrahepatic cholestasis of pregnancy (ICP) is a reversible cholestatic liver disease that may
develop during the second or third trimester of pregnancy and resolves rapidly after delivery …

Background Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that can develop
in pregnancy. It occurs when there is a build‐up of bile acids in the maternal blood. It has …

Intrahepatic Cholestasis of Pregnancy (ICP) constitutes the most common, reversible liver
disease closely connected with pregnancy and spontaneously resolving in puerperium. ICP …